• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[静脉血栓栓塞症的二级门诊预防：失访患者的结局]

[Secondary ambulatory prophylaxis of venous thromboembolism: outcome of patients who were lost to follow-up].

作者信息

Wawrzyńska L, Hajduk B, Kober J, Filipecki S

机构信息

Kliniki Chorób Wewnetrznych Instytutu Gruźlicy i Chorób Płuc w Warszawie.

出版信息

Pneumonol Alergol Pol. 1998;66(5-6):278-82.

PMID:9857647
Abstract

We have attempted to determine the outcome of 87 out-patients who were lost from follow-up. Several factors have been assessed: causes of lost from follow-up duration of oral anticoagulation, recurrent venous thromboembolic events, cause of death (if applicable).

摘要

我们试图确定87名失访门诊患者的结局。评估了几个因素：失访原因、口服抗凝治疗持续时间、复发性静脉血栓栓塞事件、死亡原因（如适用）。

相似文献

1
[Secondary ambulatory prophylaxis of venous thromboembolism: outcome of patients who were lost to follow-up].[静脉血栓栓塞症的二级门诊预防：失访患者的结局]
Pneumonol Alergol Pol. 1998;66(5-6):278-82.
2
Recurrent venous thromboembolism in patients with and without anticoagulation after inferior vena caval filter placement.下腔静脉滤器置入术后接受和未接受抗凝治疗患者的复发性静脉血栓栓塞症
Int Angiol. 2006 Mar;25(1):60-6.
3
Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.接受口服抗凝治疗的实体瘤和静脉血栓栓塞性疾病患者的血浆凝血标志物。
Clin Cancer Res. 2004 Nov 1;10(21):7238-43. doi: 10.1158/1078-0432.CCR-04-0445.
4
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.华法林预防复发性静脉血栓栓塞后的癌症发生率。抗凝治疗持续时间试验。
N Engl J Med. 2000 Jun 29;342(26):1953-8. doi: 10.1056/NEJM200006293422604.
5
[Ambulatory follow-up in oral anticoagulation: recommendations for clinical practice].
Schweiz Med Wochenschr. 1996 Mar 23;126(12):471-6.
6
[Ambulatory venous thromboembolitic disease. Clinical, etiological and evolutive data].[非卧床静脉血栓栓塞性疾病。临床、病因及演变数据]
Presse Med. 1994 May 14;23(18):839-44.
7
Anticoagulation period in idiopathic venous thromboembolism. How long is enough?特发性静脉血栓栓塞症的抗凝期。多长时间足够？
Saudi Med J. 2004 Jul;25(7):848-51.
8
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.深静脉血栓形成的临床病程。对528例有症状患者的前瞻性长期随访。
Haematologica. 1997 Jul-Aug;82(4):423-8.
9
The impact of pharmacist-managed oral anticoagulation therapy in older veterans.药剂师管理的口服抗凝治疗对老年退伍军人的影响。
J Clin Pharm Ther. 2007 Feb;32(1):21-9. doi: 10.1111/j.1365-2710.2007.00792.x.
10
Extended prophylaxis of venous thromboembolism with idraparinux.依达肝素对静脉血栓栓塞的延长预防
N Engl J Med. 2007 Sep 13;357(11):1105-12. doi: 10.1056/NEJMoa067703.